Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,730 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
Stein R, Chen S, Haim S, Goldenberg DM. Stein R, et al. Cancer. 1997 Dec 15;80(12 Suppl):2636-41. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2636::aid-cncr39>3.3.co;2-n. Cancer. 1997. PMID: 9406718
Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell lines.
Stein R, Smith MR, Chen S, Zalath M, Goldenberg DM. Stein R, et al. Clin Cancer Res. 2009 Apr 15;15(8):2808-17. doi: 10.1158/1078-0432.CCR-08-1953. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351768 Free PMC article.
A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies.
Brard PY, Karacay H, Stein R, Sharkey RM, Mattes MJ, Chang CH, Rossi EA, McBride WJ, Goldenberg DM. Brard PY, et al. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5564s-5571s. doi: 10.1158/1078-0432.CCR-07-1204. Clin Cancer Res. 2007. PMID: 17875790
CD74: a new candidate target for the immunotherapy of B-cell neoplasms.
Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM. Stein R, et al. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5556s-5563s. doi: 10.1158/1078-0432.CCR-07-1167. Clin Cancer Res. 2007. PMID: 17875789 Review.
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
Sapra P, Stein R, Pickett J, Qu Z, Govindan SV, Cardillo TM, Hansen HJ, Horak ID, Griffiths GL, Goldenberg DM. Sapra P, et al. Clin Cancer Res. 2005 Jul 15;11(14):5257-64. doi: 10.1158/1078-0432.CCR-05-0204. Clin Cancer Res. 2005. PMID: 16033844
Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
Stein R, Govindan SV, Hayes M, Griffiths GL, Hansen HJ, Horak ID, Goldenberg DM. Stein R, et al. Clin Cancer Res. 2005 Apr 1;11(7):2727-34. doi: 10.1158/1078-0432.CCR-04-2100. Clin Cancer Res. 2005. PMID: 15814655
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD, Ely S, Reddy PK, Stein R, Gold DV, Cardillo TM, Goldenberg DM. Burton JD, et al. Clin Cancer Res. 2004 Oct 1;10(19):6606-11. doi: 10.1158/1078-0432.CCR-04-0182. Clin Cancer Res. 2004. PMID: 15475450
2,730 results
Jump to page
Feedback